Net profit of Kilitch Drugs (India) rose 95.06% to Rs 4.74 crore in the quarter ended September 2023 as against Rs 2.43 crore during the previous quarter ended September 2022. Sales rose 34.20% to Rs 41.20 crore in the quarter ended September 2023 as against Rs 30.70 crore during the previous quarter ended September 2022. ParticularsQuarter Ended�Sep. 2023Sep. 2022% Var. Sales41.2030.70 34 OPM %20.9212.87 - PBDT7.602.44 211 PBT6.781.55 337 NP4.742.43 95 Powered by Capital Market - Live News

Kilitch Drugs (India) will hold a meeting of the Board of Directors of the Company on 9 November 2023.Powered by Capital Market - Live News

Kilitch Drugs (India) announced that the 31st Annual General Meeting (AGM) of the company will be held on 29 September 2023.Powered by Capital Market - Live News

Net profit of Kilitch Drugs (India) rose 60.77% to Rs 3.36 crore in the quarter ended June 2023 as against Rs 2.09 crore during the previous quarter ended June 2022. Sales rose 9.30% to Rs 36.56 crore in the quarter ended June 2023 as against Rs 33.45 crore during the previous quarter ended June 2022. ParticularsQuarter Ended�Jun. 2023Jun. 2022% Var. Sales36.5633.45 9 OPM %16.9010.22 - PBDT5.243.72 41 PBT4.532.90 56 NP3.362.09 61 Powered by Capital Market - Live News

Kilitch Drugs (India) will hold a meeting of the Board of Directors of the Company on 11 August 2023.Powered by Capital Market - Live News